Total Funding
69
67
Total FundingVenture - Series Unknown raised
Growth Score
9 pts
Heat Score
14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
31094
Svelte Medical Systems is a healthcare company engaged in the design and development of highly deliverable balloon expandable stents.
Acquired by 
Advanced Bifurcation Systems
Keith Roberts: VP, OperationsPast Role: Andera, Vice President of Operations
Richard Spencer: Vice President of Sales and MarketingPast Role: Viacor, VP, Marketing & Business Development
About the Company
Svelte Medical Systems (Svelte) is a privately held company focused on delivering novel products in the $5 billion coronary stent market. Its mission is to address key clinical issues in the stent market by improving stent deliverability, reducing cost, and dramatically improving the safety of the device compared to current market products.
Svelte
has developed the lowest profile and most deliverable balloon-expandable stent in the market, along with technology to create a non-thrombogenic, non-inflammatory Drug-Eluting Stent (DES).
Svelte was started by Robert Fischell, David Fischell, and Tim Fischell in 2007.
